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BACKGROUND 
Food is an essential requirement of everyday life, but occasionally, contamination with pathogenic bacteria can result in illness and even death. According to the European Food Safety Authority (EFSA), food-borne illnesses are one of the leading causes of 
morbidity and mortality in the world, and it was estimated that approximately one third of the population may be affected by such diseases in developed countries every year. 
Ensuring food safety involves a wide range of microbial control measures applied to relevant steps in the food chain. Currently, the most effective means to limit microbial growth are good hygiene in the production and proper use of biocides and 
disinfectants. However, these treatments are inefficient and can produce organoleptic variations or the possibility of leaving toxic waste. Consequently, the development of effective and safe natural methods has been an interesting topic during the last 
years. Phage therapy emerges as one of the solutions becoming a good approach to reduce the incidence of food-borne diseases. 
 
 
 
 
 
 
 
BIOCONTROL OF Salmonella 
In the European Union, salmonellosis is the second reported zoonotic disease in humans. Although the numbers of reported outbreaks caused by vegetables 
and products has increased, poultry and derivates are still the common sources of Salmonella. The following table shows several studies concerning phage 
therapy against Salmonella. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biocontrol of Salmonella in primary production 
Year Product Phage(s) Strategy Conclusions 
2007 Poultry φ151, φ25, φ10 Oral delivery Reduction of CFU with phages φ151 and φ10, not 
observed with φ25. Significant numbers of phages are 
required to adsorb to individual host cells. Importance of 
accessible receptors on cell surface to allow adsorption. 
2007 Poultry CB4φ, WT45φ (cocktail) Oral delivery Significant reduction at 24h, not at 48h. Emergence of 
resistant cells. 
2012 Poultry UAB_Phi20, UAB_Phi78, 
UAB_Phi87(cocktail) 
Oral delivery Importance of administering the phage prior to infection 
and continued administration to achieve significant 
protection. 
2012 Poultry φCJ07 Oral delivery (via 
feed) 
CFU reduction in uninfected chickens. ΦCJ07 to prevent 
cross contamination in poultry. 
2013 Poultry φst1 Intracloacal delivery Salmonella was not detected at and after 24h. Intracloacal 
administration avoids contact with stomach. 
2013 Poultry 
(eggs) 
F1O55S, F12013S (cocktail) Spray delivery F1O55S and F12013S reduce Salmonella horizontal 
transmission during egg incubation. 
2011 Swine Phage cocktail Oral delivery Reduction of  Salmonella within 96h. Bacteriophages can 
reduce Salmonella in swine. 
Biocontrol of Salmonella in postharvest food 
Year Product Phage(s) Strategy Conclusions 
2003 Chicken skin P22, 29C Applied on top MOI (multiplicity of infection) 100-1000 caused more 
reduction than MOI 1 and eradicated resistant strains. 
2001 Fresh-cut fruit Phage cocktail Added to foods Significant CFU reduction on melon but not on apple. pH 
of apples inactive bacteriophages. 
2004 Sprouting seeds Phage cocktail Applied by 
immersion 
Significant reduction. It is important to develop phage 
cocktails to control a wide range of contaminants. 
2012 Ready-to-eat 
food 
F01-E2 Added to foods Significant reduction of CFU in hot dogs, cooked sliced 
turkey breast, mixed seafood and chocolate milk at 15ºC. 
 
 
FACTORS AFFECTING THE 
EFFECTIVENESS OF PHAGE THERAPY 
The effectiveness of phage applications against pathogenic bacteria depends on 
several factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
- This work reflects that bacteriophages are a remarkable alternative to control 
and eradicate pathogenic bacteria in primary production and postharvest food. 
- The application of phage therapy is strengthened by the number of companies 
around the world investing in the production of phage-based products for use in 
the food industry. SALMONELEX™, for example, is a phage-based product to 
control Salmonella in the food chain.  
-  However, regulatory agencies are careful with the application of bacteriophages 
because of the lack of scientific evidence through clinical trials fully supervised by 
ethics committees and regulatory compliance standards. 
 
 
 
 
 
 
 
 
PHAGE THERAPY 
Historically, phage therapy arose to control resistant bacteria because of the 
widespread problem of antibiotic resistance coupled with the paucity of new 
antibacterial drugs. Even so, the interest has been renewed for the control of 
bacteria in other areas, including food. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
BACTERIOPHAGES IN FOOD INDUSTRY 
The use of bacteriophages to promote food safety can be mainly done at three different stages along the food chain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To reduce pathogen 
colonization in animals 
during primary production. 
 
Disinfection of food contact 
surfaces and equipments. Directly in postharvest food, such as 
meat, fresh fruit, vegetables and 
processed RTE foods.  
Directly in postharvest food, such as 
meat carcasses, fresh fruit, vegetables 
and processed ready-to-eat (RTE) 
foods. 
Advantages and disadvantages of phage therapy 
Advantages Disadvantages 
Highly specific, rapid bacterial 
killing, ability to self-replicate and 
natural. 
Narrow host range. Mixture 
(cocktail) usually required. 
Minimal disruption to regular 
microbiota. 
Knowledge of biology often 
required. 
Does not affect organolpetic 
properties. 
Negative consumer perception. 
Abundant in natural environments. 
Effective in biofilms. 
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Dose and 
moment of 
treatment. 
  Early 
treatment (or 
prior to 
infection), 
continued 
administration 
 
Concentration. 
 MOI from 0.01 to 100. 
 
 
 
Neutralization 
by immune 
system or 
other 
compounds. 
 Repeating 
the 
administration, 
increasing the 
doses, 
encapsulation. 
 
 
Administration. 
 Oral, 
intracloacal, 
topical, 
intraperitoneal, 
intranasal or 
intravenous. 
Food conditions (pH, 
temperature…) 
 Encapsulation. 
Accessibility to target bacteria 
(intracellular cells are inaccessible, 
limited diffusion in solid matrices). 
 
Specificity 
and 
resistance 
to phage.  
 Use of a 
cocktail. 
 
